The Plus SideZ: A GLP-1 Guide to Metabolic Health

Kim Carlos

Looking for real information on GLP-1 medications and weight loss? You’re in the right place. The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health. We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health. Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias. Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness. Our Linktree  https://linktr.ee/theplussidez Want to donate? PayPalhttps://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZNGoFundMehttps://gofund.me/82c8138eShop The Plus SideZ Merch Storehttps://the-plus-sidez-podcast.printify.me/products/1Website https://theplussidez.com/

PLUS SIDEZ FANZ

Get exclusive episodes, early access, and more

$5.99/mo or $59.99/yr after trial

  1. 5d ago ·  Video

    The World Has More GLP-1s but Who Can Afford Them? Part 2

    Linktree - our favorite links (https://linktr.ee/dinosaurmonkeyfarts) NEW: Need GLP-1 Care? Join me at Belle! Use Podcast at checkout to save! https://link.joinbelle.com/podcast NEW: Cozy Butter GLP-1 Community! Join Free (https://cozybutter.com/) https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. Live GLP-1 support groupsLive support groups and social eventsHealth coaching and expert Q&AsCooking, movement, and stress-management classesGLP-1 tools and guidance (water, protein, side effect management, etc.) A dedicated community beyond the algorithmBook at 1 on 1 with Kim (https://calendly.com/theplussidez/kim...)   The World Has More GLP-1s but Who Can Afford Them? Part 2 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 2, we discuss: • Managing daily life and side effects on GLP-1 medication • Why weight loss slows and plateaus happen • How the body’s set point may affect weight • What GLP-1 maintenance really means • Balancing continued weight loss with stabilization • Adjusting treatment for long-term care • What Ireland could learn from the U.S. rollout of GLP-1 medications Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment Send us Fan Mail! Support the show Kim Carlos, Executive Producer  TikTok Instagram  Kat Carter,  Producer  TikTok Instagram

    The World Has More GLP-1s but Who Can Afford Them? Part 2
  2. 6d ago • Subscribers Only

    The World Has More GLP-1s but Who Can Afford Them? Part 2

    Linktree - our favorite links https://linktr.ee/dinosaurmonkeyfarts NEW: Cozy Butter GLP-1 Community! Join Free https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. - Live GLP-1 support groups - Live support groups and social events - Health coaching and expert Q&As - Cooking, movement, and stress-management classes - GLP-1 tools and guidance (water, protein, side effect management, etc.) Book at 1 on 1 with Kim https://calendly.com/theplussidez/kim ______________________________________________________________________ This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 2, we discuss: • Managing daily life and side effects on GLP-1 medication • Why weight loss slows and plateaus happen • How the body’s set point may affect weight • What GLP-1 maintenance really means • Balancing continued weight loss with stabilization • Adjusting treatment for long-term care • What Ireland could learn from the U.S. rollout of GLP-1 medications Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy

  3. Sep 7 • Subscribers Only

    The World Has More GLP-1s but Who Can Afford Them? Part 2

    Linktree - our favorite links https://linktr.ee/dinosaurmonkeyfarts NEW: Cozy Butter GLP-1 Community! Join Free https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. - Live GLP-1 support groups - Live support groups and social events - Health coaching and expert Q&As - Cooking, movement, and stress-management classes - Practical GLP-1 tools and guidance (water, protein, side effect management, etc.) - A dedicated community beyond the algorithm Book at 1 on 1 with Kim https://calendly.com/theplussidez/kim?back=1&month=2026-09 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 2, we discuss: • Managing daily life and side effects on GLP-1 medication • Why weight loss slows and plateaus happen • How the body’s set point may affect weight • What GLP-1 maintenance really means • Balancing continued weight loss with stabilization • Adjusting treatment for long-term care • What Ireland could learn from the U.S. rollout of GLP-1 medications Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment

  4. Sep 1 ·  Video

    The World Has More GLP-1s but Who Can Afford Them? Part 1

    Linktree - our favorite links NEW: Cozy Butter GLP-1 Community! Join Free https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. - Live GLP-1 support groups - Live support groups and social events - Health coaching and expert Q&As - Cooking, movement, and stress-management classes - Practical GLP-1 tools and guidance (water, protein, side effect management, etc.) - A dedicated community beyond the algorithm Book at 1 on 1 with Kim ______________________________________________________________________ The World Has More GLP-1s but Who Can Afford Them? Part 1 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 1, we discuss: • How fat functions in the body and why it is considered an organ • GLP-1 access, costs and treatment criteria in Ireland • Which obesity medications were available in Ireland • Differences between obesity care in Ireland and the United States • Weight bias in healthcare and society • Why obesity requires medical care, not more blame Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience using GLP-1 medication and navigating obesity care. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment ______________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! The Podcast Promo Ad Support the show Kim Carlos, Executive Producer  TikTok Instagram  Kat Carter,  Producer  TikTok Instagram

    The World Has More GLP-1s but Who Can Afford Them? Part 1
  5. Sep 1 • Subscribers Only

    The World Has More GLP-1s but Who Can Afford Them? Part 1

    Linktree - our favorite links https://linktr.ee/dinosaurmonkeyfarts NEW: Cozy Butter GLP-1 Community! Join Free https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. - Live GLP-1 support groups - Live support groups and social events - Health coaching and expert Q&As - Cooking, movement, and stress-management classes - Practical GLP-1 tools and guidance (water, protein, side effect management, etc.) - A dedicated community beyond the algorithm Book at 1 on 1 with Kim https://calendly.com/theplussidez/kim?back=1&month=2026-09 The World Has More GLP-1s but Who Can Afford Them? Part 1 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 1, we discuss: • How fat functions in the body and why it is considered an organ • GLP-1 access, costs and treatment criteria in Ireland • Which obesity medications were available in Ireland • Differences between obesity care in Ireland and the United States • Weight bias in healthcare and society • Why obesity requires medical care, not more blame Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience using GLP-1 medication and navigating obesity care. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment

  6. Aug 26 ·  Video

    GLP-1 vs. Big Food: Is the Food Industry Trying to Outsmart the Medications?

    Linktree for Community Resources https://linktr.ee/theplussidez Join our free GLP-1 Community! www.CozyButter.com  Book a 1 on 1 Session with Kim - Code PLUS10 to save https://calendly.com/theplussidez/kim ______________________________________________________________________ GLP-1 vs. Big Food: Is the Food Industry Trying to Outsmart the Medications? What role has the food industry played in obesity, and how are GLP-1 medications changing what companies put on grocery store shelves? Food scientist Liam Kincaid joins Kim and Bear to take us inside the science and psychology of food. They explore what makes certain foods easy to overeat, why novelty keeps us coming back, and whether sugar, preservatives, or any single ingredient deserves the blame. Liam also explains why the grams of protein on a label do not tell the whole story, how to identify higher-quality protein sources, and why adding protein does not automatically make something “GLP-1 friendly.” Plus, they discuss how GLP-1s can change cravings and food preferences, whether the food industry is trying to work around the medications’ effects, and why fiber, savory flavors, and entirely new products may shape the future of food. This is an honest conversation about food, biology, access, and why people living with obesity deserve better than blame or another shiny label. Follow Liam: LinkedIn https://www.linkedin.com/in/liam-kincaid-ba498022a TikTok https://www.tiktok.com/t/ZP87VgedS/ APOTHIKS Food Consulting https://www.apothiks.com  _____________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! The Podcast Promo Ad Support the show Kim Carlos, Executive Producer  TikTok Instagram  Kat Carter,  Producer  TikTok Instagram

    GLP-1 vs. Big Food: Is the Food Industry Trying to Outsmart the Medications?
  7. Aug 19 ·  Video

    GLP-1s, Bariatric Surgery & the Uncomfortable Truth About Eating Disorders

    Join a Paid Support Group -  Coupon Code PLUS30 Book It Here *This episode discusses eating disorders, disordered eating, substance use, body image, and other sensitive topics. Please take care of yourself while listening. In Part 2 of Kat's conversation with Nanette Adams, MEd, LPC, LMHC, they have a candid discussion about eating disorders, substance use, and obesity care from both a professional and lived-experience perspective. Nanette is a therapist specializing in obesity and eating disorders, an obesity advocate, and a person living with obesity who has experienced both bariatric surgery and GLP-1 treatment herself. Together, she and Kat explore how our relationships with food, movement, our bodies and other coping behaviors can change throughout obesity treatment, and why eating disorders can be particularly difficult to recognize when weight loss is being celebrated. You'll leave with a better understanding of how eating disorders and substance use can intersect with obesity treatment, why they can be missed in higher-weight bodies, and when you or someone you love may need additional support. Connect with Nanette: Weighted Wisdoms: https://weightedwisdoms.com Substack: https://weightedwisdoms.substack.com Instagram: @nanetteadamslpc TikTok: @weightedwisdoms Facebook: Weighted Wisdoms Support & Resources If you or someone you love is struggling with an eating disorder, disordered eating, substance use or mental health, support is available. National Alliance for Eating Disorders Therapist-staffed helpline: 866-662-1235 Monday–Friday, 9 a.m.–7 p.m. ET Find treatment and eating disorder support: https://www.findedhelp.com/ https://www.allianceforeatingdisorders.com/ SAMHSA National Helpline 1-800-662-HELP (4357) Free, confidential treatment referral and information, available 24/7. https://www.samhsa.gov/find-help/helplines https://findtreatment.gov/ If you are in crisis: Call or text 988 for the 988 Suicide & Crisis Lifeline. If you are experiencing a medical emergency or are in immediate danger, call 911. Send us Fan Mail! Support the show Kim Carlos, Executive Producer  TikTok Instagram  Kat Carter,  Producer  TikTok Instagram

    GLP-1s, Bariatric Surgery & the Uncomfortable Truth About Eating Disorders
4.5
out of 5
239 Ratings

About

Looking for real information on GLP-1 medications and weight loss? You’re in the right place. The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health. We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health. Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias. Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness. Our Linktree  https://linktr.ee/theplussidez Want to donate? PayPalhttps://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZNGoFundMehttps://gofund.me/82c8138eShop The Plus SideZ Merch Storehttps://the-plus-sidez-podcast.printify.me/products/1Website https://theplussidez.com/

You Might Also Like